Zosano Pharma Corp (ZSAN) Interim CEO John Peter Walker Bought $100,254 of Shares
- By insider
Interim CEO of Zosano Pharma Corp (ZSAN) John Peter Walker bought 73,716 shares of ZSAN on 05/25/2017 at an average price of $1.36 a share. The total cost of this purchase was $100,254.
Zosano Pharma Corp is a clinical stage specialty pharmaceutical company. It develops a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of various indications. Zosano Pharma Corp has a market cap of $58.400 million; its shares were traded at around $1.49 .
Warning! GuruFocus has detected 2 Warning Signs with ZSAN. Click here to check it out.
The intrinsic value of ZSAN
CEO Recent Trades:
Interim CEO John Peter Walker bought 73,716 shares of ZSAN stock on 05/25/2017 at the average price of $1.36. The price of the stock has increased by 9.56% since.
Interim CEO John Peter Walker bought 73,716 shares of ZSAN stock on 05/25/2017 at the average price of $1.36. The price of the stock has increased by 9.56% since.
CFO Recent Trades:
CFO and Chief Business Officer Georgia Erbez bought 68,000 shares of ZSAN stock on 05/25/2017 at the average price of $1.32. The price of the stock has increased by 12.88% since.
For the complete insider trading history of ZSAN, click here
.This article first appeared on GuruFocus.
Warning! GuruFocus has detected 2 Warning Signs with ZSAN. Click here to check it out.
The intrinsic value of ZSAN